Improvement in predicting tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme

Cancer Science

Volumn 99, Issue 12, 2008, Pages 2435-2443

  Kanai, Masahiro ^a   Ishii, Kenichiro ^a   Kanda, Hideki ^a   Ogura, Yuji ^a   Kise, Hideaki ^a   Arima, Kiminobu ^a   Sugimura, Yoshiki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BETA CATENIN; KI 67 ANTIGEN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SIZE; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MESENCHYME; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RAT; RECOMBINANT DNA TECHNOLOGY; STROMA CELL; UROGENITAL SINUS;

ANDROGENS; ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MESODERM; MICE; MICE, SCID; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROSTATIC NEOPLASMS; RATS; UROGENITAL SYSTEM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 57349120052     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00975.x     Document Type: Article

References (42)

1. Gronberg H. Prostate cancer epidemiology. Lancet 2003; 361: 859-64.
2. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate 1941. J Urol 2002; 167: 948-51; discussion 52.
3. Bogdanos I, Karamanolakis D, Milathianakis C, Tsintavis A. New strategies for the treatment of hormone-independent prostate cancer. J Buon 2002; 7: 107-12.
4. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979; 17: 16-23.
5. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978; 21: 274-81.
6. Horoszewicz JS, Leong SS, Chu TM et al. The LNCaP cell line -a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980; 37: 115-32.
7. Onishi T, Yamakawa K, Franco OE, Suzuki R, Kawamura J. p27Kip1 is the key mediator of phenylacetate induced cell cycle arrest in human prostate cancer cells. Anticancer Res 2000; 20: 3075-81.
8. Iguchi K, Otsuka T, Usui S et al. Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. J Androl 2004; 25: 154-61.
9. Cunha GR. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 1994 (Aug 1); 74 (3 Suppl): 1030-44.
10. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-11.
11. Bhowmick NA, Chytil A, Plieth D et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-51.
12. Kawada M, Inoue H, Masuda T, Ikeda D. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. Cancer Res 2006; 66: 4419-25.
13. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: The missing link of tumor microenvironment. J Urol 2005; 173: 10-20.
14. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl 1992; 13: 465-75.
15. Hallows RC, Bone EJ, Jones W. A new dimension in the culture of human breast. In: Richards R, Rajan K, eds. Tissue Culture in Medical Research. Oxford: Pergamon Press, 1980; 213-20.
16. Ishii K, Shappell SB, Matusik RJ, Hayward SW. Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma. Lab Invest 2005; 85: 1086-103.
17. Hayward SW, Haughney PC, Rosen MA et al. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation 1998; 63: 131-40.
18. Wang Y, Sudilovsky D, Zhang B et al. A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res 2001; 61: 6064-72.
19. Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Cancer Res 2000; 60: 6630-40.
20. Baldi E, Bonaccorsi L, Forti G. Androgen receptor: Good guy or bad guy in prostate cancer invasion? Endocrinology 2003; 144: 1653-5.
21. Verras M, Sun Z. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 2006; 237: 22-32.
22. Jaggi M, Johansson SL, Baker JJ, Smith LM, Galich A, Balaji KC. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Urol Oncol 2005; 23: 402-6.
23. Nawrocki B, Polette M, Van Hengel J, Tournier JM, Van Roy F, Birembault P. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol 1998; 153: 1521-30.
24. Noel A, Foidart JM. The role of stroma in breast carcinoma growth in vivo. J Mammary Gland Biol Neoplasia 1998; 3: 215-25.
25. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction. Physiol Rev 1996; 76: 69-125.
26. Martin M, Pujuguet P, Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 1996; 192: 712-17.
27. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005; 65: 8887-95.
28. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8: 2912-23.
29. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
30. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle; 5: 1597-601.
31. Joesting MS, Perrin S, Elenbaas B et al. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res 2005; 65: 10423-30.
32. Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 2007; 67: 4244-53.
33. Cunha GR, Foster B, Thomson A et al. Growth factors as mediators of androgen action during the development of the male urogenital tract. World J Urol 1995; 13: 264-76.
34. Sugimura Y, Foster BA, Hom YK et al. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 1996; 40: 941-51.
35. Chung LW, Zhau HE, Ro JY. Morphologic and biochemical alterations in rat prostatic tumors induced by fetal urogenital sinus mesenchyme. Prostate 1990; 17: 165-74.
36. Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 1991; 51: 3753-61.
37. Hayashi N, Cunha GR, Wong YC. Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma. Cancer Res 1990; 50: 4747-54.
38. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 2002; 62: 6021-5.
39. Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new lines - part 1. J Urol 2005; 173: 342-59.
40. Adam RM, Orsola A, Freeman MR. A novel method for implantation of LNCaP prostate tumor cells under the renal capsule. In Vitro Cell Dev Biol Anim 2001; 37: 360-2.
41. Wang Y, Revelo MP, Sudilovsky D et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005; 64: 149-59.
42. Lee CH, Xue H, Sutcliffe M et al. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: Potential models. Gynecol Oncol 2005; 96: 48-55.